Skip to main content
Erschienen in: Cancer Causes & Control 6/2006

01.08.2006 | Original Paper

Association of Reproductive Factors, Oral Contraceptive Use and Selected Lifestyle Factors with the Risk of Ovarian Borderline Tumors: A Danish Case-control Study

verfasst von: Lene Drasbek Huusom, Kirsten Frederiksen, Estrid V. S. Høgdall, Eva Glud, Lise Christensen, Claus K. Høgdall, Jan Blaakaer, Susanne Krüger Kjær

Erschienen in: Cancer Causes & Control | Ausgabe 6/2006

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim was to examine risk factors for ovarian borderline tumors overall, and according to histological subtype (serous vs. mucinous), in a large Danish population-based case-control study.

Methods

Ovarian borderline cases and controls were recruited from 1995 to 1999, and personal interviews were conducted. In all, 202 cases and 1,564 randomly selected controls were included. The analysis was performed using multiple logistic regression models.

Results

The risk of ovarian borderline disease decreased with increasing parity (OR=0.79 per birth, 95% CI: 0.63–0.98) and older age at first birth (OR=0.67 per 5 years, 95% CI: 0.53–0.84). Both a history of breastfeeding and use of oral contraceptives reduced the risk of borderline tumor, the effect being most pronounced for serous tumors. Increasing body mass index (BMI) was associated with elevated risk of serous borderline tumor (OR=1.05 per BMI unit; 95% CI: 1.00–1.10), whereas current smoking was a strong risk factor only for mucinous tumors (OR=2.10; 95% CI: 1.22–3.60). Finally, increasing consumption of milk (all types) was found to increase the risk of borderline disease (OR=1.04 per glass milk per week; 95% CI: 1.02–1.06), and increasing intake of total lactose also increased the risk significantly (OR=1.16 per 50 gram lactose per week; 95% CI: 1.06–1.26).

Conclusion

The risk profile of ovarian borderline tumors is similar to that of ovarian carcinomas, and we observed significant etiological differences between serous and mucinous borderline tumors.
Literatur
1.
Zurück zum Zitat Elchalal, U, Dgani, R, Piura, B, et al. 1995Current concepts in management of epithelial ovarian tumors of low malignant potentialObstet Gynecol Surv506270PubMedCrossRef Elchalal, U, Dgani, R, Piura, B,  et al. 1995Current concepts in management of epithelial ovarian tumors of low malignant potentialObstet Gynecol Surv506270PubMedCrossRef
2.
Zurück zum Zitat Zanetta, G, Rota, S, Chiari, S, Bonazzi, C, Bratina, G, Mangioni, C 2001Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective studyJ Clin Oncol1926582664PubMed Zanetta, G, Rota, S, Chiari, S, Bonazzi, C, Bratina, G, Mangioni, C 2001Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective studyJ Clin Oncol1926582664PubMed
3.
Zurück zum Zitat Crispens, MA 2003Borderline ovarian tumours: a review of the recent literatureCurr Opin Obstet Gynecol153943ReviewPubMedCrossRef Crispens, MA 2003Borderline ovarian tumours: a review of the recent literatureCurr Opin Obstet Gynecol153943ReviewPubMedCrossRef
4.
Zurück zum Zitat Kaern, J, Trope, CG, Abeler, VM 1993A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982Cancer7118101820PubMed Kaern, J, Trope, CG, Abeler, VM 1993A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982Cancer7118101820PubMed
5.
Zurück zum Zitat Link, CJ, Reed, E, Sarosy, G, Kohn, EC 1996Borderline ovarian tumoursAm J Med101217225PubMedCrossRef Link, CJ, Reed, E, Sarosy, G, Kohn, EC 1996Borderline ovarian tumoursAm J Med101217225PubMedCrossRef
6.
Zurück zum Zitat Eltabbakh, GH, Natarajan, N, Piver, S, Mettlin, CJ 1999Epidemiologic differences between women with borderline ovarian tumours and women with epithelial ovarian cancerGynecol Oncol74103107PubMedCrossRef Eltabbakh, GH, Natarajan, N, Piver, S, Mettlin, CJ 1999Epidemiologic differences between women with borderline ovarian tumours and women with epithelial ovarian cancerGynecol Oncol74103107PubMedCrossRef
7.
Zurück zum Zitat Riman, T, Nilsson, S, Persson, IR 2004Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignanciesActa Obstet Gynecol Scand83783795PubMedCrossRef Riman, T, Nilsson, S, Persson, IR 2004Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignanciesActa Obstet Gynecol Scand83783795PubMedCrossRef
8.
Zurück zum Zitat Riman, T, Dickman, PW, Nilsson, S, et al. 2001Risk factors for epithelial borderline ovarian tumors: results of a swedish case-control studyGynecol Oncol83575585PubMedCrossRef Riman, T, Dickman, PW, Nilsson, S,  et al. 2001Risk factors for epithelial borderline ovarian tumors: results of a swedish case-control studyGynecol Oncol83575585PubMedCrossRef
9.
Zurück zum Zitat Risch, HA, Marrett, LD, Jain, M, Howe, GR 1996Differences in risk factors for epithelial ovarian cancer by histologic type: results of a case-control studyAm J Epidemiol144363372PubMed Risch, HA, Marrett, LD, Jain, M, Howe, GR 1996Differences in risk factors for epithelial ovarian cancer by histologic type: results of a case-control studyAm J Epidemiol144363372PubMed
10.
Zurück zum Zitat Cramer, DW, Welch, WR, Hutchinson, GB, Willett, WC, Scully, RE 1984Dietary animal fat in relation to ovarian cancer riskObstet Gynecol63833838PubMed Cramer, DW, Welch, WR, Hutchinson, GB, Willett, WC, Scully, RE 1984Dietary animal fat in relation to ovarian cancer riskObstet Gynecol63833838PubMed
11.
Zurück zum Zitat Cramer, DW, Harlow, BL, Willett, WC, et al. 1989Galactose consumption and metabolism in relation to the risk of ovarian cancerLancet26671PubMedCrossRef Cramer, DW, Harlow, BL, Willett, WC,  et al. 1989Galactose consumption and metabolism in relation to the risk of ovarian cancerLancet26671PubMedCrossRef
12.
Zurück zum Zitat Cramer, DW, Greenberg, ER, Titus-Ernstoff, L, et al. 2000A case-control study of galactose consumption and metabolism in relation to ovarian cancerCancer Epidemiol Biomarkers Prev995101PubMed Cramer, DW, Greenberg, ER, Titus-Ernstoff, L,  et al. 2000A case-control study of galactose consumption and metabolism in relation to ovarian cancerCancer Epidemiol Biomarkers Prev995101PubMed
13.
Zurück zum Zitat Larsson SC, Orsini N, Wolk A (2006) Milk, milk products and lactose intake and ovarian cancer risk: A metaanalysis of epidemiological studies. Int J Cancer 118(2):431–441 Larsson SC, Orsini N, Wolk A (2006) Milk, milk products and lactose intake and ovarian cancer risk: A metaanalysis of epidemiological studies. Int J Cancer 118(2):431–441
14.
Zurück zum Zitat Fairfield, KM, Hunter, DJ, Colditz, GA, et al. 2004A prospective study of dietary lactose and ovarian cancerInt J Cancer110271277PubMedCrossRef Fairfield, KM, Hunter, DJ, Colditz, GA,  et al. 2004A prospective study of dietary lactose and ovarian cancerInt J Cancer110271277PubMedCrossRef
15.
Zurück zum Zitat Larsson, SC, Bergkvist, L, Wolk, A 2004Milk and lactose intakes and ovarian cancer risk in the Swedish Mammography CohortAm J Clin Nutr8013531357PubMed Larsson, SC, Bergkvist, L, Wolk, A 2004Milk and lactose intakes and ovarian cancer risk in the Swedish Mammography CohortAm J Clin Nutr8013531357PubMed
17.
Zurück zum Zitat Glud, E, Kjaer, SK, Thomsen, BL, et al. 2004Hormone therapy and the impact of estrogen intake on the risk of ovarian cancerArch Intern Med16422532259PubMedCrossRef Glud, E, Kjaer, SK, Thomsen, BL,  et al. 2004Hormone therapy and the impact of estrogen intake on the risk of ovarian cancerArch Intern Med16422532259PubMedCrossRef
18.
Zurück zum Zitat Greenland, S 1995Dose-response and trend analysis in epidemiology: alternatives to categorical analysisEpidemiology6356365PubMedCrossRef Greenland, S 1995Dose-response and trend analysis in epidemiology: alternatives to categorical analysisEpidemiology6356365PubMedCrossRef
19.
Zurück zum Zitat Fathalla, MF 1972Factors in the causation and incidence of ovarian cancerObstet Gynecol Surv27751768PubMed Fathalla, MF 1972Factors in the causation and incidence of ovarian cancerObstet Gynecol Surv27751768PubMed
20.
Zurück zum Zitat Cramer, DW, Welch, WR 1983Determinants of ovarian cancer risk. II. Inferences regarding pathogenesisJ Natl Can Inst71717721 Cramer, DW, Welch, WR 1983Determinants of ovarian cancer risk. II. Inferences regarding pathogenesisJ Natl Can Inst71717721
21.
Zurück zum Zitat Adami, HO, Hsieh, CC, Lambe, M, Trichopoulos, D, Leon, D 1994Parity, age at first childbirth, and risk of ovarian cancerLancet34412501254PubMedCrossRef Adami, HO, Hsieh, CC, Lambe, M, Trichopoulos, D, Leon, D 1994Parity, age at first childbirth, and risk of ovarian cancerLancet34412501254PubMedCrossRef
22.
Zurück zum Zitat Whiteman, DC, Siskind, V, Purdie, DM, Green, AC 2003Timing of pregnancy and the risk of epithelial ovarian cancerCancer Epidemiol Biomarkers Prev124246PubMed Whiteman, DC, Siskind, V, Purdie, DM, Green, AC 2003Timing of pregnancy and the risk of epithelial ovarian cancerCancer Epidemiol Biomarkers Prev124246PubMed
23.
Zurück zum Zitat Pike, MC, Pearce, CL, Peters, R, Cozen, W, Wan, P, Wu, AH 2004Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control studyFertil Steril82186195PubMedCrossRef Pike, MC, Pearce, CL, Peters, R, Cozen, W, Wan, P, Wu, AH 2004Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control studyFertil Steril82186195PubMedCrossRef
24.
Zurück zum Zitat Cooper, GS, Schildkraut, JM, Whittemore, AS, Marchbanks, PA 1999Pregnancy recency and risk of ovarian cancerCancer Causes Control10397402PubMedCrossRef Cooper, GS, Schildkraut, JM, Whittemore, AS, Marchbanks, PA 1999Pregnancy recency and risk of ovarian cancerCancer Causes Control10397402PubMedCrossRef
25.
Zurück zum Zitat Albrektsen, G, Heuch, I, Kvale, G 1996Reproductive factors and incidence of epithelial ovarian cancer: a Norwegian prospective studyCancer Causes Control7421427PubMedCrossRef Albrektsen, G, Heuch, I, Kvale, G 1996Reproductive factors and incidence of epithelial ovarian cancer: a Norwegian prospective studyCancer Causes Control7421427PubMedCrossRef
26.
Zurück zum Zitat Chiaffarino, F, Parazzini, F, Negri, E, et al. 2001Time since last birth and the risk of ovarian cancerGynecol Oncol81233236PubMedCrossRef Chiaffarino, F, Parazzini, F, Negri, E,  et al. 2001Time since last birth and the risk of ovarian cancerGynecol Oncol81233236PubMedCrossRef
27.
Zurück zum Zitat Harlow, BL, Weiss, NS, Roth, GJ, Chu, J, Daling, JR 1988Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormonesCancer Res4858495852PubMed Harlow, BL, Weiss, NS, Roth, GJ, Chu, J, Daling, JR 1988Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormonesCancer Res4858495852PubMed
28.
Zurück zum Zitat Harris, R Whittemore, AS Itnyre, J the Collaborative Ovarian Cancer Group1992Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US cas- control studies. III. epithelial tumors of low malignant potential in white womenAm J Epidemiol13612041211PubMed Harris, R Whittemore, AS Itnyre, J the Collaborative Ovarian Cancer Group1992Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US cas- control studies. III. epithelial tumors of low malignant potential in white womenAm J Epidemiol13612041211PubMed
29.
30.
Zurück zum Zitat Green, A, Purdie, D, Bain, C, Siskind, V, Webb, PM 2001Cigarette smoking and risk of epithelial ovarian cancer (Australia)Cancer Causes Control12713719PubMedCrossRef Green, A, Purdie, D, Bain, C, Siskind, V, Webb, PM 2001Cigarette smoking and risk of epithelial ovarian cancer (Australia)Cancer Causes Control12713719PubMedCrossRef
31.
Zurück zum Zitat Marchbanks, PA, Wilson, H, Bastos, E, Cramer, DW, Schildkraut, JM, Peterson, HB 2000Cigarette smoking and epithelial ovarian cancer by histologic typeObstet Gynecol95255260PubMedCrossRef Marchbanks, PA, Wilson, H, Bastos, E, Cramer, DW, Schildkraut, JM, Peterson, HB 2000Cigarette smoking and epithelial ovarian cancer by histologic typeObstet Gynecol95255260PubMedCrossRef
32.
Zurück zum Zitat Qin, LQ, Xu, JY, Wang, PY, Hashi, A, Hoshi, K, Sato, A 2005Milk/daily products consumption, galactose metabolism and ovarian cancer; meta-analysis of epidemiological studiesEur J Cancer Prev141319PubMedCrossRef Qin, LQ, Xu, JY, Wang, PY, Hashi, A, Hoshi, K, Sato, A 2005Milk/daily products consumption, galactose metabolism and ovarian cancer; meta-analysis of epidemiological studiesEur J Cancer Prev141319PubMedCrossRef
33.
Zurück zum Zitat Cozen, W, Peters, R, Reichardt, JKV, et al. 2002Galactose-1phosphate uridyl transferase (GALT) genotype and phenotype, galactose consumption, and the risk of borderline and invasive ovarian cancer (United States)Cancer Causes Control13113120PubMedCrossRef Cozen, W, Peters, R, Reichardt, JKV,  et al. 2002Galactose-1phosphate uridyl transferase (GALT) genotype and phenotype, galactose consumption, and the risk of borderline and invasive ovarian cancer (United States)Cancer Causes Control13113120PubMedCrossRef
34.
Zurück zum Zitat Harlow, BL, Cramer, DW, Geller, J 1999The influence of lactose consumption on the association of oral contraceptive use and ovarian cancer riskAm J Epidemiol134445453 Harlow, BL, Cramer, DW, Geller, J 1999The influence of lactose consumption on the association of oral contraceptive use and ovarian cancer riskAm J Epidemiol134445453
35.
Zurück zum Zitat Kushi, LH, Mink, PJ, Folsom, AR, et al. 1999Prospective study of diet and ovarian cancerAm J Epidemiol1492131PubMed Kushi, LH, Mink, PJ, Folsom, AR,  et al. 1999Prospective study of diet and ovarian cancerAm J Epidemiol1492131PubMed
36.
Zurück zum Zitat Tzonou, A, Hsieh, CC, Polychronopoulou, A, et al. 1993Diet and ovarian cancer: a case-control study in GreeceInt J Cancer55411414PubMed Tzonou, A, Hsieh, CC, Polychronopoulou, A,  et al. 1993Diet and ovarian cancer: a case-control study in GreeceInt J Cancer55411414PubMed
37.
Zurück zum Zitat Goodman, MT, Wu, AH, Tung, KH, et al. 2002Association of dairy products, lactose, and calcium with the risk of ovarian cancerAm J Epidemiol156148157PubMedCrossRef Goodman, MT, Wu, AH, Tung, KH,  et al. 2002Association of dairy products, lactose, and calcium with the risk of ovarian cancerAm J Epidemiol156148157PubMedCrossRef
Metadaten
Titel
Association of Reproductive Factors, Oral Contraceptive Use and Selected Lifestyle Factors with the Risk of Ovarian Borderline Tumors: A Danish Case-control Study
verfasst von
Lene Drasbek Huusom
Kirsten Frederiksen
Estrid V. S. Høgdall
Eva Glud
Lise Christensen
Claus K. Høgdall
Jan Blaakaer
Susanne Krüger Kjær
Publikationsdatum
01.08.2006
Verlag
Kluwer Academic Publishers
Erschienen in
Cancer Causes & Control / Ausgabe 6/2006
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-006-0022-x

Weitere Artikel der Ausgabe 6/2006

Cancer Causes & Control 6/2006 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.